Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC885726794;26795;26796 chr2:178714089;178714088;178714087chr2:179578816;179578815;179578814
N2AB854025843;25844;25845 chr2:178714089;178714088;178714087chr2:179578816;179578815;179578814
N2A761323062;23063;23064 chr2:178714089;178714088;178714087chr2:179578816;179578815;179578814
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCT
  • RefSeq wild type template codon: GGA
  • Domain: Ig-74
  • Domain position: 28
  • Structural Position: 42
  • Q(SASA): 0.6801
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/S rs1317672432 0.082 1.0 D 0.659 0.777 0.558889990735 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 0 None 4.65E-05 0 0
P/S rs1317672432 0.082 1.0 D 0.659 0.777 0.558889990735 gnomAD-3.1.2 6.58E-06 None None None None I None 0 0 0 0 0 None 9.42E-05 0 0 0 0
P/S rs1317672432 0.082 1.0 D 0.659 0.777 0.558889990735 gnomAD-4.0.0 3.84438E-06 None None None None I None 0 0 None 0 0 None 4.70898E-05 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.3951 ambiguous 0.4644 ambiguous -0.322 Destabilizing 1.0 D 0.676 prob.neutral N 0.519816104 None None I
P/C 0.9105 likely_pathogenic 0.9421 pathogenic -0.546 Destabilizing 1.0 D 0.669 neutral None None None None I
P/D 0.8876 likely_pathogenic 0.9171 pathogenic -0.411 Destabilizing 1.0 D 0.648 neutral None None None None I
P/E 0.72 likely_pathogenic 0.7742 pathogenic -0.534 Destabilizing 1.0 D 0.655 neutral None None None None I
P/F 0.928 likely_pathogenic 0.9483 pathogenic -0.673 Destabilizing 1.0 D 0.641 neutral None None None None I
P/G 0.7427 likely_pathogenic 0.7984 pathogenic -0.414 Destabilizing 1.0 D 0.64 neutral None None None None I
P/H 0.7229 likely_pathogenic 0.7736 pathogenic -0.019 Destabilizing 1.0 D 0.617 neutral D 0.594133918 None None I
P/I 0.7766 likely_pathogenic 0.8118 pathogenic -0.228 Destabilizing 1.0 D 0.646 neutral None None None None I
P/K 0.7532 likely_pathogenic 0.7887 pathogenic -0.36 Destabilizing 1.0 D 0.651 neutral None None None None I
P/L 0.4521 ambiguous 0.5136 ambiguous -0.228 Destabilizing 1.0 D 0.629 neutral D 0.582293521 None None I
P/M 0.7284 likely_pathogenic 0.7838 pathogenic -0.396 Destabilizing 1.0 D 0.623 neutral None None None None I
P/N 0.8598 likely_pathogenic 0.8963 pathogenic -0.064 Destabilizing 1.0 D 0.63 neutral None None None None I
P/Q 0.6051 likely_pathogenic 0.6623 pathogenic -0.32 Destabilizing 1.0 D 0.648 neutral None None None None I
P/R 0.6031 likely_pathogenic 0.6539 pathogenic 0.145 Stabilizing 1.0 D 0.627 neutral D 0.587229699 None None I
P/S 0.5895 likely_pathogenic 0.6677 pathogenic -0.353 Destabilizing 1.0 D 0.659 neutral D 0.533627944 None None I
P/T 0.4117 ambiguous 0.4842 ambiguous -0.385 Destabilizing 1.0 D 0.653 neutral D 0.577710948 None None I
P/V 0.6314 likely_pathogenic 0.6736 pathogenic -0.227 Destabilizing 1.0 D 0.623 neutral None None None None I
P/W 0.9394 likely_pathogenic 0.9592 pathogenic -0.752 Destabilizing 1.0 D 0.682 prob.neutral None None None None I
P/Y 0.9021 likely_pathogenic 0.9285 pathogenic -0.451 Destabilizing 1.0 D 0.653 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.